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Myocardial hypertrophy in rats with renal Insufficiency. Increased
defatted dry wt of the heart and increased heart calcium content were
observed in subtotally nephrectomized male Sprague-Dawley rats com-
pared with sham-operated pairfed controls. Increased heart wt con-
trasted with no change of the weight of viscera (liver, spleen) and
markedly decreased weight of striated muscle. Heart wt was unchanged
after 5 days of renal insufficiency, but significantly increased after 14 or
21 days. Increased heart wt persisted despite effective beta
adrenoreceptor blockade (2 x 10 mg metroprolol/kg/day i.p.) or effec-
tive alpha-1-adrenoreceptor blockade (2 x 2 mg prazosin/kg/day i.p.).
Increased heart wt was also demonstrable despite normalization of
basal blood pressure (intraarterial blood pressure measurement in
conscious animals): blood pressure was lowered in one series with
hydralazine/nadolol in drinking water (calculated to deliver 20 and 2
mg/kg/day, respectively) and in another series with furosemide in
drinking water (15 mg/kg/day) combined with metoprolol (2 x 10
mg/kg/day i.p.). Increased heart wt was also noted despite correction of
anemia by blood transfusion (Hct> 40%) and after parathyroidectomy
in animals kept eucalcemic with high dietary calcium. Micromorpho-
metry of left ventricular myocardium in perfusion-fixed tissue showed
no significant change of the relative proportion of connective tissue and
myocardial fibers. Myocardial isomyosin pattern was changed with an
increase of fast-migrating Vl isomyosin in animals with renal insuffi-
ciency compared to sham-operated pairfed controls.
Hypertrophie myocardique chez des rats en Insuffisance rénale. Une
élévation du poids sec, dégraissé, du coeur, et une augmentation du
contenu calcique cardiaque ont été observées chez des rats males
Sprague-Dawley avec une néphrectomie subtotale, et compares avec
des contrôles appariCs ayant subi un simulacre d'intervention. Une
augmentation du poids cardiaque contrastait avec l'absence de change-
ment du poids des viscCres (foie, rate) et une diminution trés marquCe
du poids du muscle striC. Le poids du coeur Ctait inchangC aprCs 5jours
d'insuffisance rCnale, mais significativement augmentC aprCs 14 ou 21
jours. L'accroissement du poids du coeur persistait malgré un blocage
bCta-adrCnergique efficace (2 x 10 mg/mCtroprolol/kg/j, i,p.) ou un
blocage alpha-l-adrCnergique efllcace (2 x 2 mg/prazosinlkgtj, i.p.).
Une ClCvation du poids cardiaque Ctait Cgalement dCmontrable malgré
la normalisation de Ia pression sanguine de base (mesure de la pression
sanguine intra-artCrielle chez des animaux CveillCs): la pression san-
guine Ctait abaissCe dans une sCrie d'animaux recevant de
I'hydralazine/nadolol dans l'eau de boisson (calculCe pour dClivrer 20 et
2 mg/kg, respectivement) et dans une autre sCrie du furosCmide dans
l'eau de boisson (15 mg/kg/i) en association avec du mCtoprolol (2 x 10
mg/kg/j, i.p.). L'élCvation du poids du coeur Ctait Cgalement observCe
malgré Ia correction de l'anCmie par des transfusions sanguines (Hct>
40%) et aprCs parathyroidectomie chez des animaux maintenus
normocalcCmiques par un calcium alimentaire ClevC. La
micromorphomCtrie du myocarde ventriculaire gauche sur des tissus
fixes par perfusion ne montrait pas de changements signiflcatifs de la
Received for publication June 15, 1984,
and in revised form May 17, 1985
© 1985 by the International Society of Nephrology
proportion relative de tissu coonctif et de fibres myocardiques.
L'aspect de l'isomyosine myocardique Ctait modiflC avec une augmen-
tation de l'isomyosine VI migrant rapidement chez les ammaux atteints
d'insuffisance rCnale par rapport aux contrôles appariCs ayant subi un
simulacre d'intervention.
Increased heart weight in experimental uremia has been
noted for decades [1]. In recent years, several abnormalities of
myocardial function in uremia have been recognized [2], but it
has not been clarified to what extent these can be explained by
hypertension, anemia, fluid overload, or other known factors
[2, 3].
One consistent finding in uremic patients is myocardial
hypertrophy [4]. This has usually been ascribed to concomitant
hypertension or a history of hypertension [5]. In patients with
essential hypertension, cardiac hypertrophy is reversed, at least
in part, by antihypertensive treatment [6, 7]. We were im-
pressed by uncontrolled clinical observations of persisting
echocardiographic evidence of myocardial hypertrophy in dial-
ysis patients despite normotension for up to one decade. This
led us to examine whether myocardial hypertrophy in experi-
mental animals with renal insufficiency can be accounted for
completely by known factors such as hypertension, catechola-
mine excess, anemia, or parathyroid hormone excess.
In the present study, heart weight, heart calcium content,
cardiac tissue composition (micromorphometry), and electropho-
retic isomyosin pattern were examined in subtotally nephrecto-
mized rats. The effects of hypertension, catecholamine excess,
anemia, and PTH excess on heart weight were controlled by using
appropriately designed control experiments.
Methods
Animals
Male Sprague-Dawley rats (Firma Ivanovas, Kisslegg/Allgäu,
FRG) were housed in single cages at constant room temperature
(20°C) and humidity (75%) and controlled light on/light off
cycle. The animals were fed Altromin 1000 diet (175 g
protein/kg; 13800 kJ/kg/ 9.5 g Ca/kg; 6.5 g Pi/kg; 500 IU vitamin
D3/kg; Altromin Co., Lage/Lippe, FRG).
Alter a 3-day adaptation period, the left kidney was
subtotally resected under ether anesthesia. After another 7
days, the opposite right kidney was removed. Concomitantly,
control animals were sham operated (decapsulation of the
kidney). Care was taken that the adrenals were not damaged.
After the first operation, the animals were pairfed, that is, the
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Table 1. Effect of renal insufficiency on organ weight
Renal
Cont
(N=
rol
12)
insufficiency(N=12)
Urea, mg/d! 45 1.8 116 5gb
Creatinine, mg/dl 0.5 0.02 1.1 0.06"
Final body wt,g 117 4.3 111 3.8
Heart wt, mg wet wt 322 10.7 375 13.1"
Heart wt, mg dry wt 79.2 2.1 89.6 2.8"
Heart calcium, nmole/mg dry wt 4.35 0.23 4.97 0.14a
Gastrocnemius muscle, mg dry
wt 159 8 137 6
Liver, g dry wt 1.27 0.1 1.30 0.2
Spleen, mg dry wt 56 2 50 3
Data given as SEM.S< 0.05.
b P < 0.01.
Difference between animals with renal insufficiency and their
matched pairfed sham-operated controls (Wilcoxon's test for paired
differences).
control animals received exactly the amount of food that had
been consumed by a matched animal with renal insufficiency on
the previous day. The animals had free access to deionized
water. Blood pressure was monitored by tail plethysmography
[8] in the afternoon of Day 0, 3, and 8 of the experiment.
Twenty-four hr prior to the end of the experiments, a catheter
(P-SO, Portex Co., Kent, U.K.) was inserted into the femoral
artery under ether anesthesia. Intraarterial blood pressure was
measured in the morning of the following day in conscious,
non-stressed, non-restrained animals as described previously
[9].
Protocols
In two pilot series, subtotally nephrectomized animals were
sacrificed 5 or 14 days, respectively, after the second operation,
that is, resection of the contralateral kidney. In all other
experiments, which are reported in Tables 1 through 5, the
duration of uremia was 21 days. In all series, subtotally
nephrectomized animals were compared with a matched sham-
operated pairfed control.
Experiment I
A dose of 2 x 10 mg metoproloilkg body wt per day was
administered by intraperitoneal injection to experimental and
sham-operated pairfed animals. Control animals received sol-
vent i.p. Effectiveness of beta blockade was monitored at the
end of the experiment by measuring heart rate response to
isoproterenol prior to the scheduled administration of
metoprolol. Heart rate of solvent-treated and metoprolol-treat-
ed animals under basal conditions and after repeated bolus
injections of 10 pg/kg isoproterenol was registered using ECG
(Hellige, Multiscripton EK 33, Freiburg, FRG). The results are
shown in Table 2.
Experiment 2
In a second series, 2 x 2 mg prazosin/kg body wt per day was
administered by i.p. injections to experimental and sham-
operated pairfed animals. Control animals received solvent i.p.
The effectiveness of alpha-i-blockade was monitored by mea-
suring the response of arterial blood pressure to repeated bolus
injections of 4 to 400 g phenylephrine/kg in conscious, non-
stressed, non-restrained animals. The results are also shown in
Table 2.
Two series were designed to evaluate the effect of
antihypertensive treatment on heart wt. The results are shown
in Table 3.
Experiment 3
In one series, the animals received hydralazine (0.25 mg/mi)
and the betabiocker, nadolol (0.05 mg/mi), in the drinking water
designed to deliver 20 and 4 mg/kg, respectively, at a daily
water consumption of 20 mllday. Mean water consumption was
25.2 0.7 ml in control animals and 34.5 1.6 ml in animals
with renal insufficiency. To evaluate the effectiveness of treat-
ment, mean arterial blood pressure was measured in conscious,
non-stressed, non-restrained animals using intraarterial cathe-
ters (P50-polyethylene catheters, Portex Co., Kent, U.K.) at
4:00 P.M. on the 21st day of the experiment.
Experiment 4
In another series, the animals received furosemide (0.2
mg/mi) in the drinking water designed to deliver 15 mg/kg body
wt/day and simultaneously metoprolol (2 x 10 mg/kg/day i.p.).
Plasma volume (Evans blue) was measured on Day 20. Systolic
blood pressure was measured using tail plethysmography on
Day 21.
Experiment 5
In a further series, hematocrit was measured every other day
(capillary puncture of the plexus ophthalmicus). One and one-
half nil of citrated blood obtained by aortic puncture from one
animal of the same litter was administered via the jugular vein
to maintain hematocrit constantly above 40%. Control animals
were given sham blood transfusions using saline. The results
are given in Table 4.
Experiment 6
In a further series, surgical parathyroidectomy (PTX) was
performed 5 days prior to subtotal resection of the kidney.
Success of PTX was verified by a fall of plasma calcium  0.5
mmole/liter. Subsequently, PTX animals were kept on an ad
libitum high-calcium diet (C 1048 Altromin Co., Lage, Lippe,
FRG) containing 30 g Ca/kg and 6.5 g Pilkg, which was identical
in all other respects to the control diet. Serum calcium levels
were repeatedly measured throughout the experiment. On the
21st day, serum calcium was 2.55 0.1 and 2.30 0.05
mmoles/liter in controls and subtotally nephrectomized ani-
mals, respectively. The results are given in Table 5.
Experiment 7
In a further series, the calcium antagonist, diltiazem (2 x 50
mg/kg body wtlday), was administered by intraperitoneal injec-
tion to experimental and sham-operated animals. Control ani-
mals received solvent i.p. The results are given in Table 5.
Experiment 8
In a final series, trifluoperazine was given in the drinking
water calculated to deliver a daily dose of 10 (low dose) or 300
mg/kg (high dose), respectively. The high dose of trifluopera-
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Table 2. Effect of beta-i-blockade with metoprolol or alpha-i-blockade with prazosin on heart weight in rats with renal insufficiency
Metoprolol
Control
(N = 15)
Renal insufficiency(N = 15)
Control + metoprolol(N 10)
Renal insufficiency
+ metoprolol(N = 10)
Final body wt, g
MAP, Day 21, mm Hg
Heart wt, g dry wt
224 5.3
—
176 4.1
211 7.5
129 ll.6c
i98 8.3a
228 5.9
—
173 3.7
224 9.6
117 7.6
194 4,2"
Prazosin
Control
(N = 12)
Renal insufficiency(N = 12)
Control + prazosin
(N = 13)
Renal insufficiency
+ prazosin(N = 13)
Final body wt, g
MAP,Day2l,mmHg
Heart wt, g dry wt
251 9.6
111±3.4
167 6.0
240 8.3
124± 4,4a
188 5.0k
241 7.6
106±4.3
172 4.2
230 8.5
1l9±4.4
197 6.7"
Data given as x 5EM.
P < 0.05.
bp < 0.01.
Differences between pairfed matched groups (control vs. renal insufficiency and control + intervention vs. renal insufficiency + intervention).
Range 122 to 186.
Abbreviation: MAP, mean arterial pressure.
Table 3. Effect of antihypertensive treatment on heart weight in rats with renal insufficiency
Renal Control + hydralazine
Control insufficiency + nadolol
Hydralazine and gadolol (N = 13) (N = 13) (N = 13)
Renal insufficiency
+ hydralazine +
nadolol
(N = 13)
Final body wt, g 196 2.3 188 9.4 177 4.1
MAP, Day 21, mm Hg 101 2.0 127 3.1" 94 3.5
Heartwt, mgdrywt 129 3.4 147 5.2 119 4.1
175 3.8
106 4.8
135 4.2"
Renal Control + furosemide
Control insufficiency + metoprolol
Furosemide and metroprolol (N = 12) (N = 12) (N = 12)
Renal insufficiency
+ furosemide +
metoprolol(N = 12)
Final body wt, g 317 4.7 312 3.7 307 9.9
Plasma volume, mi/kg body wt 43 0.9 45 0.6° 44 1.4
BP, Day 21, mm Hg (tail plethysmography) 115 2.9 128 2.3k' Ill 1.9
Heart wt, mg dry wt 195 3.6 229 6.6" 203 3.7
299 5.9
43 1.8
115 2.0
220 5,7a
Values and abbreviations same as Table 2.
Table 4. Effect of blood transfusion on heart weight in rats with renal insufficiency
Renal Control + sham
Control insufficiency transfusion(N=9) (N=9) (N=9)
Renal insufficiency
+ blood transfusion
(N=9)
Final body wt, g 138 5.3 132 8.3 137 7,4
Final hematocrit, % 43.7 5.1 27.8 3.la 39.8 4.3°
Heart wt, mg dry wt 92.8 3.9 112.6 2,8b 87.5 3.8
125 12.8
42.6 6.4
127.1 4.8"
Values and abbreviations same as Table 2.
Analytical techniques
Blood chemistry was measured with an Autoanalyser
(Technicon, Tarrytown, New York, USA). Microhematocrit
was measured with the Coulter counter technique (Coulter
Counter®, Modell 5, Krefeld, FRG). T3 and T4 levels (antibody
Behring, Marburg, Federal Republic of Germany) were mea-
zine caused sedation, reduction of food intake, and death in a chloroform/methanol (3:1 v/v). Liver, spleen, and the
considerable proportion of the animals. gastrocnemius muscle were weighed using a similar protocol.
At the end of the respective experiments, the animals were
anesthetized with ether. Blood was obtained by aortic punc-
ture. The heart was immediately taken out and blotted; the
great vessels were trimmed off and the heart was weighed on a
microbalance (Medlar H-54 AR, Greilensee-ZUrich, Switzer-
land). Subsequently, hearts were desiccated (24 hr; 100°C) and
weighed again. Tissue was then defatted by extraction with
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Table 5. Effect of parathyroidectomy and calcium antagonist
(diltiazem) on heart weight of rats with renal insufficiency
Renal
Control + insufficiency +
parathy- parathy-
roidectomy roidectomy
Parathyroidectomy (N = 12) (N = 12)
Final body wt, g 188 4.1 148 7.5"
Heart wt, mg dry wt 158.2 3.0 170.5 3.2a
Heart calcium, nmole/mg
thy wt 5.55 0.10 6.95 0.40"
Renal insuf-
Renal insuf- Control + ficiency +
Control ficiency diltiazem diltiazem
Diltiazem (N = 14) (N = 14) (N = 14) (N = 14)
Final body wt,
g 205.1 6.0 195.2 5.9 194.3 4.8 181.1 5.4
Heart wt, mg
dry wI 143.4 3.8 160.7 4.8" 147.2 2.9 163.5 4.3"
Values and abbreviations same as Table 2.
sured with radioimmunoassay, respectively. Heart calcium was
measured by dissolving the desiccated heart tissue in 1.0 ml of
1.0 N HCI for 72 hr at room temperature. Calcium concentra-
tion in the supranatant was measured with atomic absorption
spectrophotometry (290 B, Perkin Elmer, Norwalk, Connecti-
cut, USA). Plasma volume was measured with Evans blue.
Blood samples were taken 10 and 60 mm after i.v. injection of
1.0 mg/100 g body wt of Evans blue.
Micromorphometry of the heart
In one series of animals, the abdominal aorta was catheter-
ized and tissues were fixed by retrograde perfusion at 120 mm
Hg. To flush the vasculature and induce diastolic cardiac arrest,
a dextran solution with 0.5 glliter procain-HC1 was used;
subsequently, 0.2 M phosphate buffer (pH 7.4) containing 3%
glutaraldehyde was perfused for fixation (12 mm). Five random
samples of the left ventricular subendocardium, five samples of
the left ventricular subepicardium, and three samples of the
right ventricular myocardium were selected for light and elec-
tron microscopy. Tissue was postfixed in 1% 0s04, dehydrated
in ethanol and embedded in Epon-Araldite. Semithin sections
were stained with alkaline toluidine blue and examined with
light microscopy (Standardmikroskop, Zeiss, Oberkochen,
FRG) using oil immersion and phase contrast. Ultrathin sec-
tions were stained with uranylacetate and lead citrate and
examined with an EM 10 microscope (Zeiss, Oberkochen,
FRG).
For micromorphometry, semithin sections were evaluated
according to Weibel [101 using light microscopy at a magmfica-
tion of 1,000:1. For each animal, five random samples of the
subendocardium and subepicardium, respectively, were exam-
ined; eight random test areas per section were obtained by
systematic subsampling and were analyzed with Zeiss eyepiece
containing 100 test points. With the point-counting technique,
the volumetric densities of myocardial cells and capillaries with
myocardial interstitial tissue were determined.
Pyrophosphate gel electrophoresis for myocardial isomyosins
Myosin was prepared using a modified procedure of Katz,
Repke, and Rubin [11]. Comparison of such purified myosin
with crude myosin showed no difference of isomyosin patterns
after electrophoresis in non-dissociating buffer systems. Con-
sequently, further experiments were carried out with a crude
myosin preparation. This was obtained by extracting minced
muscle pieces in a 0.1 M Na4P2O7; 0.005 M EGTA; 0.002 M
mercaptoethanol; pH 8.8 solution after Hoh, McGrath, and
White [121. The supernatant (J21C, Beckman, Fullerton, Cali-
fornia, USA) after centrifugation (180 mm; 24,000g) was stored
in 50% glycerol at —30°C.
Polyacrylamide gel electrophoresis according to Hoh,
McGrath, and White [121 was performed in a BioRad electro-
phoresis cell model 155 using BioRad materials throughout
(BioRad Co., Richmond, California, USA). Electrophoresis
buffer was recirculated at a rate of 0.8 1/mm using a continuous
flow pump (Peristaltic pump LP2, Amicon Co., Lexington,
Massachusetts, USA). Electrophoresis was performed at 4°C
using a Cobra Ultro Cryostat (Model WK5, Lorsch, Baden,
FRG) with a constant voltage of 4 V/cm by a LKB 2103 (LKB
Co., Bromma, Sweden) power supply over 24 hr. Each gel was
stained in 15 ml 1% Coomassie brilliant blue in 45% ethanol and
20% acetic acid at room temperature overnight. For destaining,
the gels were stirred in several changes of 10% acetic acid. The
gels were analyzed using a spectrophotometer (Model 300 N,
Gilford, Oberlin, Ohio, USA) at 581 nm wave length.
Statistics
Values are reported as mean SEM. For each experimental
series, animals were randomly allocated to the experimental or
control group, respectively, using random numbers. Differ-
ences between rats with renal insufficiency and their matched
sham-operated pairfed controls were tested using the non-
parametric Wilcoxon's test for paired differences.
Reagents
The following reagents were used: Prazosin (Pfizer GmbH),
Furosemide (Hoechst AG, Frankfurt, FRG), Hydralazine (Bris-
tol Co., Bergisch-Gladbach, FRG), Nadolol (Heyden Co.,
MUnchen, FRG), Trifluoperazin (Röhm Pharma, Weiterstadt,
FRG), Diltiazem (Goedecke AG, Freiburg, FRG), Metoprolol
(Astra Chemicals, Wedel, FRG), Phenylephrine (Serva Co.,
Heidelberg, FRG), Rheomacrodex® (Knoll Co., Ludwig-
shafen, FRG), Procain-HC1, glutaraldehyde, 0s04, Epon-
araldite, uranyl-acetate, lead citrate (Merck Co., Darmstadt,
FRG), Toluidine blue, EGTA, mercaptoethanol, glycerol,
Evans blue, phenylephrine (Serva Co., Heidelberg, FRG),
Chloroform, methanol (Sigma Co., Taufldrchen, FRG), Ether
(Hoechst AG, Frankfurt, FRG), Coomassie brilliant blue (Im-
perial Chemical Industries, London, UK).
Results
Heart weight and heart calcium content in rats with renal
insufficiency (Table 1)
Heart weight was unchanged in experimental animals 5 days
after subtotal nephrectomy (NX) compared to sham-operated
pairfed controls (CO), but heart calcium was increased (NX 8.1
0.1 nmoles/mg dry wt; CO 7.3 0.3; P < 0.05). However, a
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considerable increase of heart wet or dry wt and of heart
calcium content was observed in animals 14 days (data not
given) or 21 days after subtotal nephrectomy (Table 1). In each
of the 12 pairs, heart rate was higher in the animal with renal
failure. Adequacy of pairfeeding was documented by similar
body wts. Myocardial lipid content was unchanged; defatted
dry wt was 86.3 1.4% of dry weight in controls and 86.1
1.4% in animals with renal insufficiency. The finding of in-
creased heart wt contrasted with unchanged weight of liver and
spleen and decreased weight of the gastrocnemius muscle.
These findings could consistently be reproduced in numerous
independent series of experiments.
Interventions
Effects of beta-i -adrenoreceptor blockade and
alpha-i -adrenoreceptor blockade on heart weight in rats with
renal failure (Table 2)
Beta-I-adrenoreceptor blockade with metoprolol (Experiment
1) lowered but failed to normalize blood pressure in animals with
renal failure. The effectiveness of beta blockade was demon-
strated by resting bradycardia and blunted heart rate response to
i.v. bolus injections of 0.2 and 1.0 jsg of isoproterenol, respectively
(1.0 g: < 20% increase of heart rate). Despite effective beta
blockade, heart wt was greater in animals with renal failure
compared to matched control animals.
To exclude an alpha- 1-adrenoreceptor-mediated mechanism,
animals were treated with prazosine (Experiment 2). Effective-
ness of alpha-1-adrenoreceptor blockade was demonstrated by
a blunted response of mean arterial pressure (MAP) to bolus
injections of phenylephrine 0.4 to 40 g (with 0.4 g
phenylephrine: without prazosine MAP 13.2 2.6 mm Hg; 3
and 6 hr after prazosine, no increase of MAP; 12 hr after
prazosine, LMAP 3.0 1.15 mm Hg). Prazosine failed to
normalize blood pressure and heart wts.
Effects of antihypertensive treatment on heart weight in
uremia rats (Table 3)
Combined administration of hydralazine and nadolol effec-
tively normalized intraarterial blood pressure, but failed to
affect increased heart wt in animals with renal insufficiency
(Experiment 3).
Because the above antihypertensive protocol presumably did
not abolish volume expansion of uremia, a second antihyper-
tensive regimen was investigated. Animals received a combina-
tion of furosemide and metoprolol (Experiment 4). This regimen
failed to fully correct volume expansion, but normalized blood
pressure. Heart wt in treated animals with renal insufficiency
was still signfficantly greater than in sham-operated pairfed
controls, but the increment over controls tended to be less than
in untreated animals (difference not statistically significant).
Effects of blood transfusion on heart weight in rats with renal
failure (Table 4)
Anemia of animals with renal failure was avoided by blood
transfusions keeping hematocrit  40% throughout the experi-
ment (Experiment 5). Despite abrogation of anemia, heart
weight was still increased in non-anemic animals with renal
failure compared to sham-operated pairfed controls.
Effects of parathyroidectomy, calcium antagonists, and
tr(fluoperazin on heart weight in rats with renal insufficiency
(Table 5)
Increased heart wt was observed both in parathyroid-intact
and ad libitum-fed parathyroidectomized eucalcemic animals
with renal failure (Experiment 6). An increase of heart calcium
content was observed in animals with renal failure, despite
parathyroidectomy.
Furthermore, administration of high doses of diltiazem, a
calcium antagonist (Experiment 7), failed to affect heart wt of
animals with renal insufficiency and heart calcium content (data
not given).
Finally, trifluoperazin (TFP)-treated rats with renal insuffi-
ciency (10 mg/kg/day; Experiment 8) had higher heart wt than
TFP-treated control animals (CO + TFP [10] 149 5.4 mg dry
wt; NX + TFP (10) 171 5.3 mg dry wt).
Micromorphometry
In subepicardial or subendocardial left ventricular samples,
the relative proportion of muscle fibers on the one hand and
capillary lumina with interstitial connective tissue on the other
hand was similar in control animals and animals with renal
insufficiency. In controls, muscle fibers comprised 83.4 0.6%
of the total area, and in animals with renal insufficiency, muscle
fibers comprised 84.4 0.5 (difference not significant). Similar
findings were obtained in right ventricle (data not given).
Figures lA and B show representative electron micrographs of
the subendocardial myocardium of controls and animals with renal
insufficiency, respectively. There was no qualitative change of
subcelluiar organelles in animals with renal insufficiency.
Isomyosin patterns in animals with renal insufficiency
(Figures 2A and B)
Figure 2A compares the isoenzyme analysis of myosin in
pyrophosphate electrophoresis. In pairfed control animals (left
panel) the slowly migrating V3 species predominated, as docu-
mented by gel pattern and gel scan (Fig. 2B). In renal insufficiency
(right panel) a shift of myosin isoenzyme distribution towards the
faster migrating VI species was noted. The results could be
reproduced in several independent series of experiments.
Discussion
The present study clearly establishes an increase of heart
weight and myocardial fiber mass in rats with renal insuffi-
ciency. The increase in heart weight can be dissociated from
beta-i- and alpha-i -adrenoreceptor stimulation, anemia, and
hyperparathyroidism. In contrast to cardiac hypertrophy in
several models of hypertension [13], calcium antagonists failed
to prevent increased heart weight of rats with renal insuffi-
ciency. Two different antihypertensive treatment protocols
normalized basal arterial blood pressure, but failed to prevent
myocardial hypertrophy, indicating that the heart weight re-
sponse is either unrelated to elevated arterial blood pressure or
is remarkably responsive to minor blood pressure increments
over basal blood pressure. The heart weight changes were
accompanied by a shift of isomyosin pattern.
In the above experiments, an artefactual increase of heart
weight secondary to increased water or lipid content is ex-
cluded because defatted dry weight was increased. Similarly, an
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Fig. 1A. Longitudinal section of the left ventricular myocardium of control rat. (Lead citrate and uranylacetate. X 12,400) B. Longitudinal section
of the left ventricular myocardium of a rat with renal insufficiency. Shows normal ultrastructure of the myocardial cells and absence of
initochondrial or sarcoplasmic swelling. (Lead citrate and uranylacetate. x 12,400)
increase of interstitial space is excluded by micromorphometric
measurements of cross-sectional areas of fibers and interstitial
space. The extent to which increased myocardial fiber mass is
paralleled by an increase of contractile protein is not docu-
mented by quantitative data; however, as illustrated by Figures
1 A and B, qualitative examination using transmission
electronmicroscopy showed a harmonious increase of all myo-
cardial fiber components, including actomyosin filaments.
Increased myocardial fiber mass contrasts with wasting of
striated muscle; this is indicated by diminished weight of the
gastrocnemius muscle, which was taken as one representative
skeletal muscle. In previous studies, we could show that
diminished skeletal muscle mass is also paralleled by dimin-
ished whole body nitrogen content of rats with renal insuffi-
ciency compared to sham-operated pairfed control rats [14].
Several procedures were chosen to elucidate the mechanism
involved in the increase of myocardial fiber mass in renal
insufficiency.
An important role of sympathetic overactivity has been
documented for various models of myocardial hypertrophy
[15], and this has been related to increased beta-adrenergic
stimulation. Several recent observations point to increased
beta-adrenergic stimulation of the myocardium in renal insuffi-
ciency. Myocardial cAMP content was increased in rats with
renal insufficiency [161; this was associated with increased
circulating levels of norepinephnne [17] and could be abolished
by pretreatment with beta blockers. However, effective long-
term beta-i-blockade, as indicated by blunted chronotropic
response to isoproterenol, did not prevent the increase of heart
weight in animals with renal insufficiency.
Recently, norepinephrine-induced hypertrophy of cultured
rat myocardial cells was shown to be an alpha-l-adrenergic
response [18]. However, effective long-term alpha-i blockade
with prazosin, which abolished the pressor response to
phenylephrine, failed to prevent the increase of heart weight in
animals with renal insufficiency.
Anemia of various causes had been shown to cause a consid-
erable increase of heart weight in rats [19]. However, when
anemia of rats with renal insufficiency was corrected by blood
transfusion, the increase in heart weight was not abolished.
The heart is responsive to PTH. An increase of cardiac cAMP
concentration [20], heart rate [20], and contractile force [21] has
been demonstrated in heart muscle after addition of PTH in
vitro. In the present study, the increase in heart weight of
animals with renal insufficiency could be clearly dissociated
from hyperparathyroidism; despite parathyroidectomy, heart
weight was higher in eucalcemic parathyroidectomized rats
with renal insufficiency than in eucalcemic parathyroidectom-
ized control rats.
Calcium antagonists have been shown to abolish myocardial
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Fig. 2A. Isomyosin patterns in animals with renal insufficiency. A gel
scan is shown for one representative control animal (left panel) and an
animal with renal insufficiency (right panel). Note predominance of Vi
in animal with renal insufficiency. B. Respective gels for control animal
(top) and animal with renal insufficiency (below).
hypertrophy in SH rats, Dahl salt-sensitive rats, and rats with
renovascular hypertension [13]. In contrast, high doses of
diltiazem failed to abolish the increase of heart weight in
animals with renal insufficiency.
The failure of trifluoperazine to influence heart weight of
animals with renal insufficiency must not be taken to indicate
that a role of calcium/calmodulin in the genesis of myocardial
hypertrophy is excluded; the degree of inhibition of calmodulin
after the modest in vivo doses could not be directly assessed.
In agreement with previous findings [22], increased myocar-
dial calcium content was observed in the present study, inde-
pendent of parathyroid status. The important role of modifica-
tions of myocardial calcium in the genesis of myocardial dys-
function is well known since the classic studies of Fleckenstein
et al [23]. However, the role of increased myocardial calcium
content in renal insufficiency is difficult to assess because its
cellular and subcellular distribution in the hearts of animals with
renal insufficiency is unknown.
Finally, increased arterial blood pressure, that is, increased
afterload, would remain as the most logical explanation for
increased heart weight in renal insufficiency. However, in these
animals, the increase in arterial blood pressure was rather
modest compared to other experimental models of hypertension
[13]. The genesis of myocardial hypertrophy appears to be more
complex than a direct response to mechanical loading and may
involve, among others, circulating growth factors [24].
Two separate pharmacological maneuvers normalized basal
arterial blood pressure, but failed to prevent the increase in
heart weight. Although the inefficacy of hydralazine in combi-
nation with the beta blocker might be explained by increased
blood volume and increased preload, this consideration would
not explain the failure of furosemide in combination with a beta
blocker to normalize heart weight. Our experiments, however,
do not definitely exclude a role of hypertension, since blood
pressure was only measured in the basal state prior to the
scheduled administration of antihypertensive drugs. It is con-
ceivable that under non-basal stress conditions, or possibly
overnight, blood pressure was higher in animals with renal
insufficiency than in their matched controls. However, if this
were the case, the heart weight response would be remarkably
sensitive to changes of afterload.
It has recently been argued that for one-clip, two-kidney
hypertensive rats decreased myocardial inotropic response to
beta-adrenergic stimuli made the heart more dependent on
Frank Starling mechanisms for maximal pressure development
[25]. These considerations may be pertinent to the present
observations. Diminished beta agonist responsiveness [26], as
well as an increase of volume spaces and presumably preload,
are known to occur in renal insufficiency.
The increase in heart weight was accompanied by a shift of
the isomyosin pattern. In normal rat myocardium, three dif-
ferent isomyosins are present that differ with respect to their
electrophoretic mobilities and reaction kinetics [27]. Isomyosin
pattern is dependent upon age, thyroid status, physical activity,
and so forth. Young age, hyperthyroidism, or physical exercise
are associated with predominance of Vi isomyosin, that is, the
isomyosin with fast anodic mobility and fast contractile re-
sponse. In the present study, independent of animal age,
predominance of V 1 isomyosin was observed in animals with
renal insufficiency compared to pairfed controls. Circulating
total T3 and T4 levels (data not given) do not suggest the
presence of thyroid hormone excess, but concentrations of
thyroid hormone-binding proteins were not measured. It is of
note, however, that recent studies, in contrast to previous
observations, failed to show evidence for diminished action of
thyroid hormones on hepatic tissue in a model of experimental
renal insufficiency comparable to ours [28]. Physical activity
was, if anything, diminished in rats with renal insufficiency.
Consequently, the change of isomyosin pattern in rats with
renal insufficiency is presumably not explained by differences of
age, thyroid status, or physical activity.
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